Go to:
Logótipo
Comuta visibilidade da coluna esquerda
Você está em: Start > Publications > View > Computational studies on class I ribonucleotide reductase: Understanding the mechanisms of action and inhibition of a cornerstone enzyme for the treatment of cancer
Publication

Publications

Computational studies on class I ribonucleotide reductase: Understanding the mechanisms of action and inhibition of a cornerstone enzyme for the treatment of cancer

Title
Computational studies on class I ribonucleotide reductase: Understanding the mechanisms of action and inhibition of a cornerstone enzyme for the treatment of cancer
Type
Article in International Scientific Journal
Year
2006
Authors
Pereira, S
(Author)
Other
The person does not belong to the institution. The person does not belong to the institution. The person does not belong to the institution. View Authenticus page Without ORCID
Ramos, MJ
(Author)
FCUP
View Personal Page You do not have permissions to view the institutional email. Search for Participant Publications View Authenticus page View ORCID page
Journal
Vol. 35
Pages: 125-135
ISSN: 0175-7571
Publisher: Springer Nature
Scientific classification
FOS: Natural sciences > Biological sciences
Other information
Authenticus ID: P-004-PMD
Abstract (EN): This review provides a synthesis of recent work, using computational methods, on the action and inhibition mechanisms of class I ribonucleotide reductase (RNR). This enzyme catalyzes the rate-limiting step of the pathway for the synthesis of DNA monomers and, therefore, has long been regarded as an important target for therapies aiming to control pathologies that depend strongly on DNA replication. In fact, over the last years, several molecules, which are able to impair RNR activity by different mechanisms, have been applied effectively in anti-cancer, anti-viral and anti-parasite therapies. A better understanding of the chemical mechanisms involved in normal catalysis and in inhibition of the enzyme is important for the rational design of more specific and effective inhibitor compounds. To achieve this goal, computational methods, particularly quantum chemical calculations, have been used more and more frequently. The ever-growing capabilities of these methods together with undeniable advantages make it a stimulating area for research purposes.
Language: English
Type (Professor's evaluation): Scientific
Contact: pafernan@fc.up.pt
No. of pages: 11
Documents
We could not find any documents associated to the publication.
Related Publications

Of the same authors

Overview of ribonucleotide reductase inhibitors: An appealing target in anti-tumour therapy (2005)
Another Publication in an International Scientific Journal
Cerqueira, NMFSA; Pereira, S; Fernandes, PA; Ramos, MJ

Of the same journal

Biophysical characterization of Neurospora crassa membrane and its sensitivity to staurosporine. (2013)
Another Publication in an International Scientific Journal
Arnaldo Videira; FC Santos; AS Fernandes; RFM Almeida
Uncertainty in protein¿ligand binding constants: asymmetric confidence intervals versus standard errors (2021)
Article in International Scientific Journal
Paketuryt¿, V; Petrauskas, V; Zubrien¿, A; Abian, O; Bastos, M; Chen, WY; Moreno, MJ; Krainer, G; Linkuvien¿, V; Sedivy, A; Velazquez Campoy, A; Williams, MA; Matulis, D
Isothermal titration calorimetry (ITC): a standard operating procedure (SOP) (2021)
Article in International Scientific Journal
Bastos, M; Velazquez Campoy, A
A multi-laboratory benchmark study of isothermal titration calorimetry (ITC) using Ca2+ and Mg2+ binding to EDTA (2021)
Article in International Scientific Journal
Velazquez Campoy, A; Claro, B; Abian, O; Horing, J; Bourlon, L; Claveria Gimeno, R; Ennifar, E; England, P; Chaires, JB; Wu, D; Piszczek, G; Brautigam, C; Tso, SC; Zhao, HY; Schuck, P; Keller, S; Bastos, M
Recommend this page Top
Copyright 1996-2025 © Faculdade de Direito da Universidade do Porto  I Terms and Conditions  I Acessibility  I Index A-Z  I Guest Book
Page created on: 2025-07-02 at 00:19:12 | Acceptable Use Policy | Data Protection Policy | Complaint Portal